
LinearDNA: Alternative to Plasmid DNA for Therapeutic Applications
June 29th, 2022
LinearDNA: Alternative to Plasmid DNA for Therapeutic Applications
June 29th, 2022
Applied DNA Subsidiary LineaRx Receives Repeat Orders for LinearDNA
November 15th, 2021
Applied DNA Positions LinearDNA™ Platform as the Next Generation Manufacturing Platform for Adeno-Associated Virus-based Gene Therapies Through New Patent Filing
August 17th, 2020
LineaRx Receives Multiple Orders for Linear DNA for Use in Therapeutic Development
July 1st, 2019
Linear DNA Crosses the Line between Tags and Therapeutics
April 9th, 2019
APDN Forms Subsidiary, LineaRx, to Develop DNA for Biotherapeutics
September 18th, 2018
APDN Presenting Linear DNA for Gene Therapy at Boston Immuno-Oncology Summit
August 27th, 2018